[ad_1]

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon purchased 573,798 shares of the stock in a transaction on Tuesday, March 12th. The shares were bought at an average cost of $1.38 per share, for a total transaction of $791,841.24. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

CVRS stock opened at $1.98 on Friday. Corindus Vascular Robotics Inc has a 1-year low of $0.70 and a 1-year high of $2.01.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). The business had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.

Several hedge funds have recently bought and sold shares of the stock. Millennium Management LLC increased its holdings in shares of Corindus Vascular Robotics by 1.0% during the 4th quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock worth $5,955,000 after acquiring an additional 68,250 shares during the last quarter. Nomura Holdings Inc. increased its holdings in shares of Corindus Vascular Robotics by 18.6% during the 4th quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock worth $1,077,000 after acquiring an additional 198,111 shares during the last quarter. Barclays PLC acquired a new position in shares of Corindus Vascular Robotics during the 4th quarter worth approximately $325,000. Citadel Advisors LLC increased its holdings in shares of Corindus Vascular Robotics by 205.4% during the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after acquiring an additional 77,829 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Corindus Vascular Robotics during the 4th quarter worth approximately $64,000.

ILLEGAL ACTIVITY NOTICE: “Insider Buying: Corindus Vascular Robotics Inc (CVRS) Director Purchases $791,841.24 in Stock” was first reported by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.fairfieldcurrent.com/news/2019/03/16/insider-buying-corindus-vascular-robotics-inc-cvrs-director-purchases-791841-24-in-stock.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Featured Story: What is Liquidity?

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

Source link